| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.039 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |